Prospective, Single-center, Randomized Trial, Intended to Compare Three Revascularization Strategies in Patients With Multi-vessel Coronary Artery Disease
Latest Information Update: 29 Oct 2020
At a glance
- Drugs Everolimus (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms HREVS
- 01 Sep 2020 Results presented at the ESC Congress 2020 - Annual Congress of the European Society of Cardiology
- 27 Sep 2017 Status changed from active, no longer recruiting to completed.
- 03 Jun 2017 Planned End Date changed from 1 Dec 2018 to 1 Aug 2020.